Cardiovascular outcomes trials for glucose-lowering therapies : what do the results mean for practice?
Newland-Jones, Phillip
Newland-Jones, Phillip
Abstract
DigestDEBATE: In this section, a panel of multidisciplinary team members give their opinions on a recently published paper. In this issue, we discuss the outcome of the cardiovascular safety trial of empagliflozin, and what the results mean for clinical practice in the UK.
MIDER Authors
Affiliations
University of Southampton; University of Warwick; George Eliot Hospital NHS Trust, Nuneaton
Citations
Altmetric:
Date
2015-12-15
Type
Article
Subject
Collections
Citation
Newland-Jones P, Patel V. Cardiovascular outcomes trials for glucose-lowering therapies: What do the results mean for practice? Diabetes Digest. 2015 December;14(4):191-192.